×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
CODX – co-diagnostics, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
CODX
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
4/2
09:13 am
codx
Co-Diagnostics Joint Venture CoMira Receives Approval for Manufacturing Facility in Kingdom of Saudi Arabia's Sudair Industrial City [TheStreet.com]
Medium
Report
Co-Diagnostics Joint Venture CoMira Receives Approval for Manufacturing Facility in Kingdom of Saudi Arabia's Sudair Industrial City [TheStreet.com]
4/2
09:00 am
codx
Co-Diagnostics Joint Venture CoMira Receives Approval for Manufacturing Facility in Kingdom of Saudi Arabia's Sudair Industrial City
Medium
Report
Co-Diagnostics Joint Venture CoMira Receives Approval for Manufacturing Facility in Kingdom of Saudi Arabia's Sudair Industrial City
4/1
05:47 am
codx
This Diagnostics Company Is Advancing a Global Expansion Strategy, Positioning for Growth Phase [Globe and Mail, The (Toronto, Canada)]
Medium
Report
This Diagnostics Company Is Advancing a Global Expansion Strategy, Positioning for Growth Phase [Globe and Mail, The (Toronto, Canada)]
4/1
02:48 am
codx
Co-Diagnostics anticipates India TB test commercialization by Q3 '26 while exploring CoSara SPAC options [Seeking Alpha]
Medium
Report
Co-Diagnostics anticipates India TB test commercialization by Q3 '26 while exploring CoSara SPAC options [Seeking Alpha]
4/1
02:43 am
codx
Co-Diagnostics, Inc. (CODX) Q4 2025 Earnings Call Transcript [Seeking Alpha]
Medium
Report
Co-Diagnostics, Inc. (CODX) Q4 2025 Earnings Call Transcript [Seeking Alpha]
3/31
11:06 pm
codx
Co-Diagnostics Inc (CODX) Q4 2025 Earnings Call Highlights: Strategic Expansions and Financial ... [Yahoo! Finance]
Medium
Report
Co-Diagnostics Inc (CODX) Q4 2025 Earnings Call Highlights: Strategic Expansions and Financial ... [Yahoo! Finance]
3/31
04:22 pm
codx
Co-Diagnostics Reports Full Year 2025 Financial Results [Yahoo! Finance]
Medium
Report
Co-Diagnostics Reports Full Year 2025 Financial Results [Yahoo! Finance]
3/31
04:01 pm
codx
Co-Diagnostics Reports Full Year 2025 Financial Results
High
Report
Co-Diagnostics Reports Full Year 2025 Financial Results
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Symbol
Headline
Impact
3/31
04:11 pm
codx
Form 10-K Co-Diagnostics, Inc. For: Dec 31
High
Report
Form 10-K Co-Diagnostics, Inc. For: Dec 31
3/31
04:06 pm
codx
Form 8-K Co-Diagnostics, Inc. For: Mar 31
High
Report
Form 8-K Co-Diagnostics, Inc. For: Mar 31
3/10
09:26 am
codx
Form 8-K Co-Diagnostics, Inc. For: Mar 09
High
Report
Form 8-K Co-Diagnostics, Inc. For: Mar 09
2/11
10:02 am
codx
Form SCHEDULE 13G/A Co-Diagnostics, Inc. Filed by: Ayrton Capital LLC
Low
Report
Form SCHEDULE 13G/A Co-Diagnostics, Inc. Filed by: Ayrton Capital LLC
1/13
12:23 pm
codx
Form 8-K Co-Diagnostics, Inc. For: Jan 07
High
Report
Form 8-K Co-Diagnostics, Inc. For: Jan 07
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
3/10
Co-Diagnostics down 39% on proliferation of COVID-19 competitors [Seeking Alpha]
89.0%
1/23 Co-Diagnostics, Inc. Designs Test for New Coronavirus Using CoPrimer™ Platform 79.6%
1/27 Vaccine, diagnostics stocks rise again on spreading coronavirus [MarketWatch] 38.1%
2/28 Form 424B5 Co-Diagnostics, Inc. 35.0%
4/16 Co-Diagnostics, Inc. COVID-19 Test Technology Validated for Use on Saliva Samples 30.6%
2/10 Co-Diagnostics, Inc. Announces Sales of New Coronavirus Test 28.2%
7/18 Co-Diagnostics Inc CoPrimers Provide High-Performance Detection of Cancer Mutations in Liquid Biopsy Samples 26.4%
2/6 Co-Diagnostics, Inc. Announces Launch of Test for New Coronavirus 24.2%
2/24 Co-Diagnostics, Inc. Receives CE Mark for Novel Coronavirus Test 20.2%
1/31 Coronavirus update: 213 dead, more countries recommending against China travel [MarketWatch] 19.4%
1/23 Co-Diagnostics, Inc. Designs Test for New Coronavirus Using CoPrimer™ Platform 79.6%
1/27 Vaccine, diagnostics stocks rise again on spreading coronavirus [MarketWatch] 38.1%
2/28 Form 424B5 Co-Diagnostics, Inc. 35.0%
4/16 Co-Diagnostics, Inc. COVID-19 Test Technology Validated for Use on Saliva Samples 30.6%
2/10 Co-Diagnostics, Inc. Announces Sales of New Coronavirus Test 28.2%
7/18 Co-Diagnostics Inc CoPrimers Provide High-Performance Detection of Cancer Mutations in Liquid Biopsy Samples 26.4%
2/6 Co-Diagnostics, Inc. Announces Launch of Test for New Coronavirus 24.2%
2/24 Co-Diagnostics, Inc. Receives CE Mark for Novel Coronavirus Test 20.2%
1/31 Coronavirus update: 213 dead, more countries recommending against China travel [MarketWatch] 19.4%
TOP News Decliners
2/28
Why Acquisition & Coordination of First Responders Data On COVID-19 Becoming Critically Essential
-34.3%
3/9 Co-Diagnostics Inc (NASDAQ: CODX) had its price target raised by analysts at HC Wainwright from $4.00 to $20.00. They now have a "buy" rating on the stock. -28.8%
3/12 Global Response to the COVID-19 Outbreak Intensifies -25.6%
1/27 Form 424B5 Co-Diagnostics, Inc. -23.6%
2/10 Co-Diagnostics up 36% on coronavirus test sales [Seeking Alpha] -19.7%
1/31 Coronavirus update: Trump declares coronavirus a public health emergency, U.S. citizens returning from Hubei Province to be quarantined [MarketWatch] -18.5%
3/2 Co-Diagnostics CEO on FDA's coronavirus policy changes [Yahoo! Finance News] -18.4%
3/3 Faulty COVID-19 Test Kits Tilt Scales in Coronavirus's Favor [The Motley Fool] -13.7%
3/17 Co-Diagnostics says new FDA policy to help expand use of COVID-19 test [Reuters (UK)] -13.5%
2/18 Co-Diagnostics (NASDAQ:CODX) Helping to Mitigate Global Economic Risk -12.8%
3/9 Co-Diagnostics Inc (NASDAQ: CODX) had its price target raised by analysts at HC Wainwright from $4.00 to $20.00. They now have a "buy" rating on the stock. -28.8%
3/12 Global Response to the COVID-19 Outbreak Intensifies -25.6%
1/27 Form 424B5 Co-Diagnostics, Inc. -23.6%
2/10 Co-Diagnostics up 36% on coronavirus test sales [Seeking Alpha] -19.7%
1/31 Coronavirus update: Trump declares coronavirus a public health emergency, U.S. citizens returning from Hubei Province to be quarantined [MarketWatch] -18.5%
3/2 Co-Diagnostics CEO on FDA's coronavirus policy changes [Yahoo! Finance News] -18.4%
3/3 Faulty COVID-19 Test Kits Tilt Scales in Coronavirus's Favor [The Motley Fool] -13.7%
3/17 Co-Diagnostics says new FDA policy to help expand use of COVID-19 test [Reuters (UK)] -13.5%
2/18 Co-Diagnostics (NASDAQ:CODX) Helping to Mitigate Global Economic Risk -12.8%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: